Here we set outto develop mouse models of mutant KRAS-driven lung cancer with an elevated tumormutational burden by expressing the human DNA cytosine deaminase, APOBEC3B, tomimic the mutational signature seen in human lung cancer. This evidence concerns the gene APOBEC3B and lung carcinoma.